Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure

Liver International

Volumn 33, Issue 10, 2013, Pages 1517-1526

  Dong, Xiaojun ^a   Gong, Yu ^a   Zeng, Hui ^b   Hao, Yu ^b   Wang, Xianbo ^b   Hou, Jing ^c   Wang, Jiefei ^d   Li, Juan ^e   Zhu, Yueke ^e   Liu, Haixia ^e   Han, Junyan ^b   Zhou, Haiwei ^b   Shen, Liwei ^a   Gao, Ting ^a   Zhou, Tingting ^a   Yang, Shuyin ^a   Li, Shuting ^a   Chen, Yingxuan ^a   Meng, Qinghua ^d,e   Li, Hai ^a,d  

^a BEIJING HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

CD3+ T cells; CD4+ regulatory T lymphocytes; Chronic hepatitis B; Conventional T lymphocytes; HBV related acute on chronic liver failure; Septic shock

Indexed keywords

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; MALE; PHENOTYPE; REGULATORY T LYMPHOCYTE; SEPTIC SHOCK;

CD3+ T CELLS; CD4+ REGULATORY T LYMPHOCYTES; CHRONIC HEPATITIS B; CONVENTIONAL T LYMPHOCYTES; HBV-RELATED ACUTE-ON-CHRONIC LIVER FAILURE; SEPTIC SHOCK;

ADULT; ANALYSIS OF VARIANCE; CHINA; END STAGE LIVER DISEASE; FEMALE; FLOW CYTOMETRY; FLUORESCEINS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOPHENOTYPING; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; SHOCK, SEPTIC; SUCCINIMIDES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84885181109     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12248     Document Type: Article

References (66)

1. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-82.
2. Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care 2011; 17: 165-9.
3. Jalan R, Gines P, Olson JC, et al. Acute-on chronic liver failure. J Hepatol 2012; 57: 1336-48.
4. Zou Z, Chen J, Xin S, et al. Features of onset of chronic severe hepatitis in 520 cases. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2002; 16: 322-5.
5. Flink HJ, Sprengers D, Hansen BE, et al. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy. Gut 2005; 54: 1604-9.
6. Sera T, Hiasa Y, Michitaka K, et al. Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med 2006; 45: 721-4.
7. Graziadei IW. The clinical challenges of acute on chronic liver failure. Liver Int 2011; 31(Suppl. 3): 24-6.
8. Alqahtani SA. Update in liver transplantation. Discov Med 2012; 14: 133-41.
9. Inoue T, Fuke H, Yamamoto N, et al. Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection. Hepatogastroenterology 2007; 54: 889-91.
10. Zoulim F, Perrillo R. Hepatitis B: reflections on the current approach to antiviral therapy. J Hepatol 2008; 48(Suppl. 1): S2-19.
11. Guo LM, Liu JY, Xu DZ, et al. Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int 2003; 23(Suppl. 3): 16-20.
12. Li LJ, Yang Q, Huang JR, et al. Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. World J Gastroenterol 2004; 10: 2984-8.
13. Hassanein TI, Schade RR, Hepburn IS. Acute-on-chronic liver failure: extracorporeal liver assist devices. Curr Opin Crit Care 2011; 17: 195-203.
14. Wasmuth HE, Kunz D, Yagmur E, et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 2005; 42: 195-201.
15. Antoniades CG, Wendon J, Vergani D. Paralysed monocytes in acute on chronic liver disease. J Hepatol 2005; 42: 163-5.
16. Xing T, Li L, Cao H, Huang J. Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin Exp Immunol 2007; 147: 184-8.
17. Leber B, Mayrhauser U, Rybczynski M, Stadlbauer V. Innate immune dysfunction in acute and chronic liver disease. Wien Klin Wochenschr 2009; 121: 732-44.
18. Liu Q. Role of cytokines in the pathophysiology of acute-on-chronic liver failure. Blood Purif 2009; 28: 331-41.
19. Zhang Z, Zou ZS, Fu JL, et al. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J Hepatol 2008; 49: 396-406.
20. Li N, Li Q, Qian Z, et al. Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage. Biochem Biophys Res Commun 2009; 390: 630-5.
21. Shi F, Zhang JY, Zeng Z, Tien P, Wang FS. Skewed ratios between CD3(+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure. Biochem Biophys Res Commun 2010; 402: 30-6.
22. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162: 5317-26.
23. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197: 111-9.
24. Sakaguchi S, Wing K, Miyara M. Regulatory T cells - a brief history and perspective. Eur J Immunol 2007; 37(Suppl. 1): S116-23.
25. + regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
26. Kondelkova K, Vokurkova D, Krejsek J, et al. Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Medica (Hradec Kralove) 2010; 53: 73-7.
27. + regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008; 9: 239-44.
28. + regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 2006; 177: 6540-7.
29. Torgerson TR. Regulatory T cells in human autoimmune diseases. Springer Semin Immunopathol 2006; 28: 63-76.
30. Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203: 359-70.
31. + regulatory T cells is vital for infectious transplantation tolerance. J Exp Med 2011; 208: 2043-53.
32. + T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911.
33. Kumar A, Das K, Sharma P, et al. Hemodynamic studies in acute-on-chronic liver failure. Dig Dis Sci 2009; 54: 869-78.
34. Malik R, Mookerjee RP, Jalan R. Infection and inflammation in liver failure: two sides of the same coin. J Hepatol 2009; 51: 426-9.
35. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
36. Lok AS, Mcmahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-2.
37. Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002; 20: 252-61.
38. Laleman W, Verbeke L, Meersseman P, et al. Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 2011; 5: 523-37; 537.
39. Gong Y, Shen LW, Wang JF, et al. The study on the immune suppression with severity of HBV-related acute-on-chronic liver failure patients. Chin J Dig (Chinese) 2011; 31: 11-6.
40. Shen LW, Wang JF, Dong XJ, et al. Study of peripheral blood monocytes in patients with HBV-related acute-on-chronic liver failure under immune dysfunction state. Chin J Dig (Chinese) 2012; 32: 25-9.
41. Shen LW, Wang JF, Dong XJ, et al. Identification and characterization of a novel monocytes subpopulation in peripheral blood of HBV-associated acute liver failure patients. J Hepatol 2012; 54(Suppl.): S249.
42. Zhang M, Zhou J, Zhao T, et al. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states. J Infect Dis 2012; 205: 1111-20.
43. Parry RV, Chemnitz JM, Frauwirth KA, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 2005; 25: 9543-53.
44. Blank C, Mackensen A. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol Immunother 2007; 56: 739-45.
45. Keir ME, Francisco LM, Sharpe AH. PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 2007; 19: 309-14.
46. Bishop KD, Harris JE, Mordes JP, et al. Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism. Cell Immunol 2009; 256: 86-91.
47. Hofmeyer K A, Jeon H, Zang X. The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion. J Biomed Biotechnol 2011; 2011: 451694.
48. Gershon RK, Carter RL, Kondo K. On concomitant immunity in tumour-bearing hamsters. Nature 1967; 213: 674-6.
49. Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007; 13: 108-16.
50. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-86.
51. Dons EM, Raimondi G, Cooper DK, Thomson AW. Induced regulatory T cells: mechanisms of conversion and suppressive potential. Hum Immunol 2012; 73: 328-34.
52. Yang J, Yi P, Wei L, et al. Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF). J Transl Med. 2012 Sep 15; 10: 193.
53. + regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003; 31: 2068-71.
54. - lymphocytes. Crit Care Med 2004; 32: 2329-31.
55. Monneret G, Venet F. Additional bad news from regulatory T cells in sepsis. Crit Care 2010; 14: 453.
56. Venet F, Chung CS, Kherouf H, et al. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009; 35: 678-86.
57. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517.
58. Miossec P. IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 2009; 11: 625-30.
59. + T cell lineage differentiation. Immunity 2009; 30: 646-55.
60. Lee YK, Mukasa R, Hatton RD, Weaver CT. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol 2009; 21: 274-80.
61. Zhai S, Zhang L, Dang S, et al. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol 2011; 24: 303-10.
62. Xue-Song L, Cheng-Zhong L, Ying Z, Mo-Bin W. Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection. BMC Gastroenterol 2012; 12: 43.
63. Niu Y, Liu H, Yin D, et al. The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 2011; 12: 47.
64. Marwaha AK, Crome SQ, Panagiotopoulos C, et al. Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol 2010; 185: 3814-8.
65. Muthu RK, Rihova L, Zahradova L, et al. Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma. PLoS One 2012; 7: e47077.
66. Antons AK, Wang R, Oswald-Richter K, et al. Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J Immunol 2008; 180: 764-73.